Literature DB >> 24036841

Maternal ileal interposition surgery confers metabolic improvements to offspring independent of effects on maternal body weight in UCD-T2DM rats.

Bethany P Cummings1, James L Graham, Kimber L Stanhope, Michael L Chouinard, Peter J Havel.   

Abstract

BACKGROUND: Increasing numbers of people are undergoing bariatric surgery, of which approximately half are women in their childbearing years. However, information on the long-term effects of maternal bariatric surgery in their children is lacking. Furthermore, since bariatric surgery is performed to reduce body weight, clinical studies have not been able to differentiate between benefits to the child due to maternal body weight loss versus other maternal postoperative metabolic changes. Therefore, we used the University of California, Davis, type 2 diabetes mellitus (UCD-T2DM) rat model to test the hypothesis that maternal ileal interposition (IT) surgery would confer beneficial metabolic effects in offspring, independent of effects on maternal body weight.
METHODS: IT surgery was performed on 2-month-old prediabetic female UCD-T2DM rats. Females were bred 3 weeks after surgery, and male pups were studied longitudinally.
RESULTS: Maternal IT surgery resulted in decreased body weight in offspring compared with sham offspring (P < 0.05). IT offspring exhibited improvements of glucose-stimulated insulin secretion and nutrient-stimulated glucagon-like peptide-2 (GLP-2) secretion (P < 0.05). Fasting plasma unconjugated bile acid concentrations were 4-fold lower in IT offspring compared with sham offspring at two months of age (P < 0.001).
CONCLUSIONS: Overall, maternal IT surgery confers modest improvements of body weight and improves insulin secretion and nutrient-stimulated GLP-2 secretion in offspring in the UCD-T2DM rat model of type 2 diabetes, indicating that this is a useful model for investigating the weight-independent metabolic effects of maternal bariatric surgery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24036841      PMCID: PMC3855031          DOI: 10.1007/s11695-013-1076-y

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  34 in total

1.  Rapid analysis of conjugated bile acids in plasma using electrospray tandem mass spectrometry: application for selective screening of peroxisomal disorders.

Authors:  A H Bootsma; H Overmars; A van Rooij; A E van Lint; R J Wanders; A H van Gennip; P Vreken
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

2.  Dietary-resistant starch improves maternal glycemic control in Goto-Kakizaki rat.

Authors:  Li Shen; Michael J Keenan; Anne Raggio; Cathy Williams; Roy J Martin
Journal:  Mol Nutr Food Res       Date:  2011-06-03       Impact factor: 5.914

Review 3.  Fetal origins of obesity.

Authors:  Emily Oken; Matthew W Gillman
Journal:  Obes Res       Date:  2003-04

4.  Vertical sleeve gastrectomy improves glucose and lipid metabolism and delays diabetes onset in UCD-T2DM rats.

Authors:  Bethany P Cummings; Ahmed Bettaieb; James L Graham; Kimber L Stanhope; Mark Kowala; Fawaz G Haj; Michael L Chouinard; Peter J Havel
Journal:  Endocrinology       Date:  2012-06-19       Impact factor: 4.736

Review 5.  Preservation of β-cell function: the key to diabetes prevention.

Authors:  Ralph A DeFronzo; Muhammad A Abdul-Ghani
Journal:  J Clin Endocrinol Metab       Date:  2011-06-22       Impact factor: 5.958

Review 6.  Preventing and treating obesity in girls and young women to curb the epidemic.

Authors:  John G Kral
Journal:  Obes Res       Date:  2004-10

7.  Separation and quantitation of bile acids using an isocratic solvent system for high performance liquid chromatography coupled to an evaporative light scattering detector.

Authors:  E C Torchia; E D Labonté; L B Agellon
Journal:  Anal Biochem       Date:  2001-11-15       Impact factor: 3.365

8.  Intestinal growth adaptation and glucagon-like peptide 2 in rats with ileal--jejunal transposition or small bowel resection.

Authors:  J Thulesen; B Hartmann; H Kissow; P B Jeppesen; C Orskov; J J Holst; S S Poulsen
Journal:  Dig Dis Sci       Date:  2001-02       Impact factor: 3.199

Review 9.  Bariatric surgery: a systematic review and meta-analysis.

Authors:  Henry Buchwald; Yoav Avidor; Eugene Braunwald; Michael D Jensen; Walter Pories; Kyle Fahrbach; Karen Schoelles
Journal:  JAMA       Date:  2004-10-13       Impact factor: 56.272

Review 10.  Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system.

Authors:  P L Brubaker; D J Drucker
Journal:  Endocrinology       Date:  2004-03-24       Impact factor: 4.736

View more
  4 in total

1.  Maternal Roux-en-Y gastric bypass impairs insulin action and endocrine pancreatic function in male F1 offspring.

Authors:  Carla Bruna Pietrobon; Iala Milene Bertasso; Rosane Aparecida Ribeiro; Ana Claudia Paiva Alegre-Maller; Camila Lubaczeuski; Antonio Carlos Boschero; Allan Cezar Faria Araújo; Sandra Lucinei Balbo; Maria Lúcia Bonfleur
Journal:  Eur J Nutr       Date:  2019-04-13       Impact factor: 5.614

Review 2.  The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: a systematic review.

Authors:  N C Penney; J Kinross; R C Newton; S Purkayastha
Journal:  Int J Obes (Lond)       Date:  2015-06-17       Impact factor: 5.095

3.  Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota.

Authors:  Ying Wang; Haiyi Liu; Miaoyan Zheng; Yanhui Yang; Huizhu Ren; Yan Kong; Shanshan Wang; Jingyu Wang; Yingying Jiang; Juhong Yang; Chunyan Shan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-07       Impact factor: 5.555

Review 4.  Zucker Diabetic-Sprague Dawley (ZDSD) rat: Type 2 diabetes translational research model.

Authors:  Andrea N Wang; Joselia Carlos; Graham M Fraser; John J McGuire
Journal:  Exp Physiol       Date:  2022-03-08       Impact factor: 2.858

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.